CDC Director Rochelle Walensky accepted the agency’s recommendation that the Vaccination be given to children aged 5 to 11 years old in the United States. On Friday, the US Food and Drug Administration approved the vaccine for use in children aged 5 to 11. The US Centers for Disease Control and Prevention (CDC) had previously unanimously endorsed the use of Pfizer and BioNTech’s COVID-19 vaccine in children aged 5 to 11, with doses perhaps being administered as early as Wednesday.
They claim that the benefits of Vaccination exceed the hazards. The vaccine has been connected to rare incidences of heart inflammation in young males, which has sparked a lot of concern. In young children, the FDA approved a 10-microgram dose of Pfizer’s vaccine. The first 30 microgram shot was administered to persons aged 12 and up. Walensky stated at the opening of the meeting that paediatric hospitalizations had increased during the recent coronavirus outbreak caused by the Delta variant.
The White House announced earlier this week that the Pfizer/BioNTech vaccine is sufficient for all 28 million youngsters aged 5 to 11. While some youngsters may be able to get their first doses as early as Wednesday, the US paediatric vaccine programme is expected to be fully operational by next week, according to a Biden administration official.